18f-fp-dtbz
Small moleculeexperimentalImaging agent
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
1
Phase 4
0
Earliest trial started Jul 1, 2013 (NCT02236754)
Timeline
Indications
Mechanism of action
- Unspecified targetRadiopharmaceutical
radiopharmaceutical
Chemistry & pharmacology
- Imaging
- 18-fluorine
Oral
No
Parenteral
No
Topical
No
Also known as
- 18f-fp-dtbz
- 18f-fp-dtbz
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02138864 | Phase 3 | Aug 1, 2013 | Chang Gung University |
| NCT02236754 | Early Phase 1 (Phase 1) | Jul 1, 2013 | Columbia University, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Chang Gung University | Academic/Hospital | 1 | 1 | 1 | 2013 |
| Columbia University | Academic/Hospital | 1 | 1 | 1 | 2013 |
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Government | 1 | 0 | 1 | 2013 |
3 organizations
Page 1 / 1